Amarin Corporation plc (AMRN) Balance Sheet

The balance sheet is contracting in lockstep with the top-line deterioration, with total assets down $165.6M over the period. This suggests the company is consuming its asset base to fund operations, as retained losses accumulate and no new capital is being raised. The trend indicates a weakening financial position that may limit strategic flexibility.

Amarin's debt levels are trivial, with total debt never exceeding $12.2M in the past ten quarters, and the D/E ratio consistently below 0.03. While this suggests low refinancing risk, it also implies the company is not leveraging up to fund growth, possibly because lenders are wary given the revenue decline. The absence of debt could be a sign of conservatism or a constraint on capital access.

The asset base is dominated by current assets, with PPE representing less than 1% of total assets, underscoring a low capital intensity typical of a commercial-stage biotech. The steady decline in goodwill and intangibles, from $18.6M to $12.1M, suggests ongoing amortization or impairment, which may reflect the diminishing value of acquired assets as revenue falls. This trend warrants monitoring for potential further write-downs.

The equity base is being steadily eroded by ongoing net losses, with retained earnings stuck at -$1.7B and no sign of reversal. The decline in equity, from $545.9M to $443.6M, reflects the company's inability to generate sustainable profits, and the absence of share repurchases or dividends indicates all capital is being retained to fund operations. This trend suggests that without a turnaround, equity could continue to shrink, potentially impacting solvency perceptions.

Despite a current ratio above 3.0 throughout the period, the absolute cash balance has fallen by $70.9M, reflecting ongoing cash burn from operations. The high current ratio is partly due to reduced current liabilities, but the declining cash trend suggests that the liquidity buffer is being consumed. Given the revenue slide and operating losses, investors should monitor whether cash levels can sustain operations without additional financing.